Subscribe to MDT Magazine News

WellPoint spent $1.1 M on 3Q federal lobbying

December 17, 2010 10:45 am | by The Associated Press | Comments

Health insurer WellPoint Inc. spent $1.1 million lobbying the federal government in the third quarter, as it focused on several issues tied to the health care overhaul Congress passed in March.The Indianapolis insurer lobbied on Medicare Advantage and implementation of the overhaul, which aims...

GE Healthcare finishes first part of Clarient bid

December 17, 2010 10:45 am | by The Associated Press | Comments

GE Healthcare said Friday that it completed the first part of its offering for diagnostic services company Clarient Inc.The General Electric Co. unit agreed in October to buy Clarient for $570 million in cash, or about $5 per share. GE Healthcare said about 84 percent of Clarient's common and...

Katz joins NeuroMetrix board

December 17, 2010 10:33 am | by Mass High Tech: The Journal of New England Technology | Comments

NeuroMetrix Inc., a Waltham-based developer of medical devices and therapies to treat neurological and spinal conditions, has appointed Nancy Katz to its board of directors.


FDA Workshop - Assuring the Safety and Effectiveness of Seizure, Cognitive Function, and TBI/Sports Concussion Diagnostic Devices, June 2-3, 2011

December 17, 2010 10:33 am | by U.S. Food & Drug Administration | Comments

Attendees will discuss approaches and endpoints for clinical studies for these devices and how the results should be conveyed to the users so that the devices may be used effectively.

RXi plans IND for anti-scarring treatment

December 17, 2010 10:33 am | by Mass High Tech: The Journal of New England Technology | Comments

RXi Pharmaceuticals Corp. of Worcester is preparing to bring its first RNAi product into development, with the filing of an investigational new drug (IND) application for its therapeutic candidate in reducing surgical scarring.

Accuray Establishes Medical Affairs Function

December 17, 2010 9:33 am | by Bio-Medicine.Org | Comments

SUNNYVALE, Calif., Dec. 17, 2010 /- Accuray Incorporated (Nasdaq: ARAY ), a global leader in the field of radiosurgery, announced today that the company has established a Medical Affairs function to accelerate CyberKnife data collection, utilization and referral patterns and to provide...


Boston researchers test treatment for autism link

December 17, 2010 9:32 am | by Mass High Tech: The Journal of New England Technology | Comments

Children's Hospital Boston scientists have initiated a three-year clinical trial to test a potential treatment for Rett Syndrome, known to cause autism in girls.


Anzemet (dolasetron mesylate): Drug Safety Communication - Reports of Abnormal Heart Rhythms

December 17, 2010 8:34 am | by U.S. Food & Drug Administration | Comments

Injection form of Anzemet (dolasetron mesylate) should no longer be used to prevent nausea and vomiting associated with cancer chemotherapy in pediatric and adult patients.


VIDEO From Siemens and Synaptic Digital: Not Your Father's X-Ray Machine

December 17, 2010 8:32 am | by Bio-Medicine.Org | Comments

NEW YORK, Dec. 17, 2010 /- Say so-long to the days of black and white 2-D X-rays and images. From CT, to MRI and PET, medical imaging is faster, more detailed, and three-dimensional and is revolutionizing the way medicine is practiced.  Thanks to years of improved imaging, today's...


Cephalon founder, CEO Frank Baldino Jr. dies at 57

December 17, 2010 7:45 am | by The Associated Press | Comments

Cephalon Inc. Chairman and CEO Frank Baldino Jr. died Thursday evening, the biotechnology company said. He was 57.Chief Operating Officer J. Kevin Buchi took over Baldino's day-to-day responsibilities in August and will continue doing that, said Fritz Bittenbender, vice president for public...

An ITG Majestic Market Research Study Indicates a Bright Future for Gilenya, Despite Concerns About Its Safety

December 17, 2010 7:31 am | by Bio-Medicine.Org | Comments

NEW YORK, Dec. 17, 2010 /- A study published this week by ITG (NYSE: ITG ) revealed that Novartis recently approved drug, Gilenya, has already taken share from market leaders in the multiple sclerosis (MS) market, and uptake is expected to increase significantly over the next year.  ...


BG Medicine backs out of IPO

December 17, 2010 6:31 am | by Mass High Tech: The Journal of New England Technology | Comments

On the cusp of going public, BG Medicine Inc. has pulled its IPO, Dow Jones reports. BG, which is developing a cardiac diagnostic test, initially filed to go public in January with plans for an $86.3 million offering before scaling back twice prior to pulling the plug.


Cardinal Health Receives Regulatory Clearance for Kinray Acquisition

December 17, 2010 6:31 am | by Bio-Medicine.Org | Comments

DUBLIN, Ohio, Dec. 17, 2010 /- Cardinal Health today announced that the Federal Trade Commission has granted early termination of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 for its proposed acquisition of Kinray, Inc., a leading pharmaceutical...


Call for speakers to present at IQPC's MEDCon, the Medical Electronic Device Conference and Expo

December 17, 2010 5:36 am | by MEDCon | Comments

The Medical Electronic Device Conference & Expo (MEDCon), being held May 16 - 18, 2011 at Navy Pier in Chicago focuses on specific needs of electrical and design engineers for medical devices.


Beetroot juice could help people live more active lives

December 17, 2010 5:31 am | by EurekAlert | Comments

(University of Exeter) New research into the health benefits of beetroot juice suggests it's not only athletes who can benefit from its performance enhancing properties -- its physiological effects could help the elderly or people with heart or lung-conditions enjoy more active lives.



You may login with either your assigned username or your e-mail address.
The password field is case sensitive.